Condition
Post-Transplant Lymphoproliferative Disorder clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Post-Transplant Lymphoproliferative Disorder clinical trials that are recruiting, at sites in 2 countries (most in United States (2), China (1)). By phase: Phase 1/2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 2Countries
Newest Post-Transplant Lymphoproliferative Disorder clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| First-line therapy with Loncastuximab Tesirine and Rituximab for PTLD after transplant | Phase 1/2 | Salt Lake City, Utah | Recruiting | May 7, 2026 |
| EBV-targeted T-cell therapy for persistent EBV DNAemia after allogeneic transplant | Phase 1/2 | Beijing | Recruiting | Jan 26, 2026 |
| BZLF1 peptide vaccine with QS-21 to prevent EBV-related cancers in patients awaiting organ transplants | Phase 1 | Columbus, Ohio | Recruiting | Dec 18, 2024 |
All recruiting trials (3)
-
First-line therapy with Loncastuximab Tesirine and Rituximab for PTLD after transplant
This trial tests if loncastuximab tesirine plus rituximab can help adults with post-transplant lymphoproliferative disorder after a transplant.
-
EBV-targeted T-cell therapy for persistent EBV DNAemia after allogeneic transplant
This treatment will try infusing EBV-specific TCR-engineered T cells into adults with persistent or rising EBV DNA after an allogeneic stem cell transplant to see if the virus clears and the therapy is safe.
-
BZLF1 peptide vaccine with QS-21 to prevent EBV-related cancers in patients awaiting organ transplants
This early-phase trial tests a BZLF1-based vaccine (OSU-2131) with QS-21 to see if it is safe and can help prevent EBV infection and related cancers in healthy people and in patients waiting for a solid organ transplant.
Related topics
Quick answers
How many Post-Transplant Lymphoproliferative Disorder clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (2 trials), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.